Proceeding contribution from Baroness Harman (Labour) in the House of Commons on Thursday, 22 October 2009. It occurred during Business statement on Business of the House.
Business of the House
I will draw that question to the attention of my right hon. Friend the Secretary of State for Health. I know that the National Institute for Health and Clinical Excellence approved very important treatment for wet macular degeneration, but I am not familiar with the criteria, under the NICE regulations, that govern the availability of medication. I shall ask Ministers to look into the matter.
Secondary information
- Type
- Proceeding contribution
- Reference
- 497 c1068
- Session
- 2008-09
- Chamber / Committee
- House of Commons chamber
- Subjects
- Health services Macular degeneration
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2023-11-25 20:01:19 +0000
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1455757/answer
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1455757/answer
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1455757/answer